Tumour Necrosis Factor TNF is crucial for defence but can drive chronic inflammation linked to arthritis and autoimmune diseases when overproduced ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

Research uncovers how P-stalk ribosomes regulate cytokine responses, driving immune evasion in tumors across multiple cancer ...

Shufeng Jiedu Capsules (SFJD), a traditional Chinese medicine preparation, are widely used in the clinical treatment of influenza, yet their mechanism of action remains unclear.

DeepCure, a therapeutics company using AI to discover novel drugs for inflammation and immune diseases, will present new in vivo data demonstrating its selective BRD4 (BD2) inhibitor DC-9476 is ...

ACELYRIN, INC. (SLRN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Derek ...

Ginger may contain beneficial components, including gingerols and shogaols. These compounds are thought to have antioxidant ...

Sankyo sent visiting researchers to UAB to promote the collaboration, and so Ichikawa had the opportunity to continue studying the molecular mechanisms ... member of the TNF receptor family ...

Thomas Bieber, University of Bonn, Germany, wasted no time in welcoming his colleagues from around the world to the ...

The work transforms the understanding of the body’s response to infections and opens the way to treatments against ...